2002
DOI: 10.1046/j.1460-9568.2002.02030.x
|View full text |Cite
|
Sign up to set email alerts
|

Genomic responses of the brain to ischemic stroke, intracerebral haemorrhage, kainate seizures, hypoglycemia, and hypoxia

Abstract: RNA expression profiles in rat brain were examined 24 h after ischemic stroke, intracerebral haemorrhage, kainate-induced seizures, insulin-induced hypoglycemia, and hypoxia and compared to sham- or untouched controls. Rat oligonucleotide microarrays were used to compare expression of over 8000 transcripts from three subjects in each group (n = 27). Of the somewhat less than 4000 transcripts called 'present' in normal or treated cortex, 5-10% of these were up-regulated 24 h after ischemia (415), haemorrhage (2… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

21
162
0

Year Published

2003
2003
2022
2022

Publication Types

Select...
9
1

Relationship

3
7

Authors

Journals

citations
Cited by 204 publications
(183 citation statements)
references
References 153 publications
(161 reference statements)
21
162
0
Order By: Relevance
“…A linear scaling procedure was performed so that signal intensities for all genes on an array are multiplied by a scaling factor that makes the average intensity value for each array equal to a preset value of 1500 (Tang et al, 2002). This procedure scaled the average intensity of all the arrays to the same level and made the comparison among different samples possible.…”
Section: Methodsmentioning
confidence: 99%
“…A linear scaling procedure was performed so that signal intensities for all genes on an array are multiplied by a scaling factor that makes the average intensity value for each array equal to a preset value of 1500 (Tang et al, 2002). This procedure scaled the average intensity of all the arrays to the same level and made the comparison among different samples possible.…”
Section: Methodsmentioning
confidence: 99%
“…Thus, significant upregulation of these proteins has been observed in a number of human neurological diseases, including Alzheimer's disease (55,(79)(80)(81)(82)), Pick's disease (79), short-course Creutzfeld-Jakob disease (72), amyotrophic lateral sclerosis (83)(84)(85), and multiple sclerosis (86,87). Experiments carried out in animal models fully demonstrated the response of MT-1&2 to brain damage elicited by inflammatory factors such as lipopolysaccharides (11, 15, 24, 88), stress (62,(89)(90)(91), glutamate analogues (37,51,59,(92)(93)(94)(95), cryogenic injury (28,32,66,71), stroke/ischemia (17, [95][96][97][98], familial amyotrophic lateral sclerosis models (38,67,99,100), multiple sclerosis models (101)(102)(103), and gliotoxins (104)(105)(106).…”
Section: Transgenic Mice Show That Metallothionein-1and2 Are Essential mentioning
confidence: 99%
“…In animals, a specific gene expression profile has been shown in both brain tissue and blood following ischemic stroke [6][7][8][9]. In humans, brain tissue is rarely available.…”
Section: Ribonucleic Acid (Rna) Biomarkers In Ischemic Strokementioning
confidence: 99%